Eli Lilly revenue and financials
In the fiscal year ended December 2025, Eli Lilly reported revenue of $65.18B (+44.70% year over year). Net income was $20.64B, a net margin of 31.7%.
Fiscal year ending in December. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +44.70%
- 2025 vs 2024
- Net income growth
- +94.90%
- 2025 vs 2024
- Net margin
- 31.7%
- 2024: 23.5%
How Eli Lilly is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 21.6% a year on average over the last 5 years
Compound annual growth rate: from $24.54B in 2020 to $65.18B in 2025.
Revenue has grown for 8 fiscal years in a row
Each fiscal year compared with the one before, up to 2025.
Operating margin rose from 30.3% to 45.6%
Operating income over revenue, 2022 → 2025: 15.2 percentage points.
Less cash than profit: free cash flow equal to 37% of net income
Totals for fiscal years 2023–2025: free cash flow $13.52B, net income $36.47B.
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 65,179 | 45,043 | 34,124 | 28,541 | 28,318 | 24,540 | 22,320 | 21,493 | 19,974 | 21,222 |
| Cost of revenue | 11,052 | 8,418 | 7,082 | 6,630 | 7,313 | 5,483 | 4,721 | 4,682 | 4,448 | 5,710 |
| Gross profit | 54,127 | 36,625 | 27,042 | 21,912 | 21,345 | 19,057 | 17,598 | 16,812 | 15,526 | 15,512 |
| Selling, general and administrative | 11,094 | 8,594 | 7,404 | 6,068 | 6,142 | 5,869 | 6,004 | 5,735 | 5,733 | 6,330 |
| Research and development | 13,337 | 10,991 | 9,313 | 7,191 | 6,931 | 5,976 | 5,595 | 5,051 | 5,096 | 5,310 |
| Operating income | 29,696 | 17,040 | 10,325 | 8,653 | 8,273 | 7,211 | 5,999 | 6,026 | 4,697 | 3,871 |
| EBIT | 29,696 | 17,040 | 10,325 | 8,653 | 8,273 | 7,211 | 5,999 | 6,026 | 4,697 | 3,871 |
| EBITDA | 31,693 | 18,807 | 11,852 | 10,176 | 9,820 | 8,535 | 7,232 | 7,635 | 6,264 | 5,271 |
| Interest expense | — | 781 | 486 | 332 | 340 | 360 | 401 | 243 | 225 | 185 |
| Pre-tax income | 25,731 | 12,680 | 6,554 | 6,806 | 6,156 | 7,230 | 5,266 | 3,680 | 2,305 | 3,374 |
| Income tax | 5,091 | 2,090 | 1,314 | 562 | 574 | 1,036 | 628 | 530 | 2,391 | 636 |
| Net income | 20,640 | 10,590 | 5,240 | 6,245 | 5,582 | 6,194 | 8,318 | 3,232 | -204 | 2,738 |
| Net income to common shareholders | 20,640 | 10,590 | 5,240 | 6,245 | 5,582 | 6,194 | 4,638 | 3,151 | -86.4 | 2,738 |
| Basic EPS | 23.00 | 11.76 | 5.82 | 6.93 | 6.15 | 6.82 | 8.93 | 3.14 | -0.19 | 2.59 |
| Diluted EPS | 22.95 | 11.71 | 5.80 | 6.90 | 6.12 | 6.79 | 8.89 | 3.13 | -0.19 | 2.58 |
| Average shares (basic) | 897 | 901 | 900 | 902 | 907 | 908 | 931 | 1,028 | 1,052 | 1,058 |
| Average shares (diluted) | 899 | 904 | 903 | 905 | 912 | 913 | 936 | 1,034 | 1,052 | 1,062 |
| Dividend per share | 6.00 | 5.20 | 4.52 | 3.92 | 3.40 | 2.96 | 2.58 | 2.25 | 2.08 | 2.04 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 24,397 | 22,974 | 19,799 | 19,292 | 17,601 | 15,558 | 12,729 | 13,533 | 11,439 | 11,303 | 8,768 | 9,353 |
| Cost of revenue | 3,933 | 3,268 | 3,577 | 3,372 | 3,008 | 2,448 | 2,225 | 2,404 | 2,171 | 2,170 | 1,674 | 1,788 |
| Gross profit | 20,464 | 19,706 | 16,222 | 15,920 | 14,593 | 13,110 | 10,504 | 11,130 | 9,268 | 9,133 | 7,095 | 7,565 |
| Selling, general and administrative | 3,125 | 3,430 | 2,934 | 3,458 | 2,627 | 2,753 | 2,468 | 2,771 | 1,984 | 2,003 | 1,836 | 1,810 |
| Research and development | 4,247 | 3,819 | 3,510 | 3,802 | 3,466 | 3,336 | 2,734 | 3,023 | 2,734 | 2,711 | 2,523 | 2,563 |
| Operating income | 13,092 | 12,457 | 9,778 | 8,661 | 8,500 | 7,021 | 5,302 | 5,336 | 4,550 | 4,419 | 2,736 | 3,193 |
| EBIT | 13,092 | 12,457 | 9,778 | 8,661 | 8,500 | 7,021 | 5,302 | 5,336 | 4,550 | 4,419 | 2,736 | 3,193 |
| EBITDA | 13,626 | 12,991 | 10,287 | 9,247 | 8,970 | 7,499 | 5,765 | 5,821 | 5,017 | 4,833 | 3,136 | 3,581 |
| Interest expense | 316 | 345 | 332 | 153 | 180 | 249 | 244 | 131 | 193 | 184 | 180 | 138 |
| Pre-tax income | 8,406 | 9,247 | 8,850 | 8,266 | 7,232 | 6,777 | 3,456 | 5,038 | 1,588 | 3,517 | 2,536 | 2,509 |
| Income tax | 1,955 | 2,152 | 1,454 | 1,629 | 1,650 | 1,116 | 697 | 629 | 618 | 550 | 293 | 319 |
| Net income | 6,451 | 7,095 | 7,396 | 6,638 | 5,583 | 5,661 | 2,759 | 4,410 | 970 | 2,967 | 2,243 | 2,190 |
| Net income to common shareholders | 6,451 | 7,095 | 7,396 | 6,638 | 5,583 | 5,661 | 2,759 | 4,410 | 970 | 2,967 | 2,243 | 2,190 |
| Basic EPS | 7.22 | 7.95 | 8.27 | 7.39 | 6.22 | 6.30 | 3.07 | 4.88 | 1.08 | 3.29 | 2.49 | 2.42 |
| Diluted EPS | 7.22 | 7.94 | 8.26 | 7.39 | 6.21 | 6.29 | 3.06 | 4.88 | 1.07 | 3.28 | 2.48 | 2.42 |
| Average shares (basic) | 893 | 892 | 895 | 898 | 897 | 898 | 899 | 903 | 901 | 901 | 901 | 904 |
| Average shares (diluted) | 893 | 894 | 896 | 898 | 899 | 900 | 901 | 903 | 905 | 904 | 904 | 904 |
| Dividend per share | 1.73 | 1.73 | 1.73 | 1.50 | 1.50 | 1.50 | 1.50 | 1.30 | 1.30 | 1.30 | 1.30 | 1.13 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 112,476 | 78,715 | 64,006 | 49,490 | 48,806 | 46,633 | 39,286 | 43,908 | 44,981 | 38,806 |
| Current assets | 55,629 | 32,740 | 25,727 | 18,035 | 18,452 | 17,462 | 13,710 | 20,550 | 19,202 | 15,101 |
| Cash and equivalents | 7,268 | 3,268 | 2,819 | 2,067 | 3,819 | 3,657 | 2,338 | 7,998 | 6,536 | 4,582 |
| Short-term investments | — | 155 | 109 | 145 | 90.1 | 24.2 | 101 | 88.2 | 1,498 | 1,457 |
| Receivables | 20,116 | 12,939 | 11,093 | 8,302 | 8,113 | 6,888 | 5,523 | 5,696 | 5,235 | 4,732 |
| Inventory | 13,744 | 7,589 | 5,773 | 4,310 | 3,886 | 3,980 | 3,191 | 3,098 | 4,458 | 3,562 |
| Net property, plant and equipment | 25,935 | 18,152 | 13,938 | 10,144 | 8,985 | 8,682 | 7,873 | 7,996 | 8,827 | 8,253 |
| Goodwill | 5,898 | 5,770 | 4,940 | 4,073 | 3,892 | 3,767 | 3,679 | 4,348 | 4,370 | 3,973 |
| Other intangible assets | 6,521 | 6,166 | 6,907 | 7,207 | 7,692 | 7,450 | 6,618 | 1,068 | 4,029 | 4,358 |
| Long-term investments | 2,802 | 3,216 | 3,407 | 3,201 | 3,405 | 3,198 | 2,126 | 2,018 | 5,714 | 5,276 |
| Current liabilities | 35,228 | 28,376 | 27,293 | 17,138 | 15,053 | 12,482 | 11,775 | 11,888 | 14,536 | 10,987 |
| Accounts payable | 5,379 | 3,229 | 2,599 | 1,931 | 1,671 | 1,607 | 1,405 | 1,207 | 1,411 | 1,349 |
| Long-term debt | 40,868 | 29,474 | 19,105 | 14,815 | 16,741 | 16,349 | 13,639 | 11,640 | 9,941 | 9,006 |
| Total debt | 43,865 | 30,453 | 20,275 | 14,875 | 16,927 | 16,886 | 13,870 | 9,876 | 11,020 | 9,006 |
| Total liabilities | 85,941 | 64,443 | 53,143 | 38,714 | 39,651 | 40,808 | 36,587 | 32,999 | 33,313 | 24,725 |
| Total equity (incl. minority) | 26,535 | 14,272 | 10,864 | 10,775 | 9,155 | 5,825 | 2,699 | 10,909 | 11,668 | 14,081 |
| Retained earnings | 24,470 | 13,545 | 10,312 | 10,043 | 8,959 | 7,830 | 4,920 | 11,396 | 13,894 | 16,046 |
| Minority interest | — | 79.5 | 91.8 | 126 | 176 | 184 | 92.2 | 1,080 | 75.7 | 72.8 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | — | 142,283 | 116,576 | 112,476 | 114,935 | 100,923 | 89,389 | 78,715 | 75,607 | 71,875 | 63,944 | 64,006 |
| Current assets | — | 64,672 | 54,835 | 55,629 | 62,071 | 49,854 | 41,261 | 32,740 | 31,415 | 30,204 | 25,189 | 25,727 |
| Cash and equivalents | — | 8,950 | 5,282 | 7,268 | 9,792 | 3,376 | 3,093 | 3,268 | 3,369 | 3,224 | 2,460 | 2,819 |
| Short-term investments | — | — | — | — | 122 | 170 | 127 | — | 149 | 140 | 126 | 109 |
| Receivables | — | 23,475 | 21,136 | 20,116 | 19,131 | 16,421 | 13,900 | 12,939 | 12,029 | 12,993 | 9,874 | 11,093 |
| Inventory | — | 16,793 | 14,529 | 13,744 | 12,180 | 11,014 | 9,311 | 7,589 | 7,460 | 6,482 | 6,102 | 5,773 |
| Net property, plant and equipment | — | 29,286 | 26,540 | 25,935 | 22,316 | 20,530 | 18,474 | 18,152 | 16,172 | 14,829 | 13,624 | 13,938 |
| Goodwill | — | 8,849 | 6,130 | 5,898 | 5,898 | 5,771 | 5,771 | 5,770 | 5,768 | 5,768 | 4,940 | 4,940 |
| Other intangible assets | — | 18,110 | 7,374 | 6,521 | 6,447 | 5,908 | 6,012 | 6,166 | 6,537 | 6,636 | 6,762 | 6,907 |
| Long-term investments | — | 3,856 | 3,116 | 2,802 | 2,928 | 3,328 | 3,287 | 3,216 | 3,268 | 2,925 | 3,129 | 3,407 |
| Current liabilities | — | 47,741 | 36,634 | 35,228 | 40,141 | 39,020 | 30,068 | 28,376 | 24,674 | 27,121 | 18,598 | 27,293 |
| Accounts payable | — | 6,112 | 5,029 | 5,379 | 4,262 | 4,076 | 3,442 | 3,229 | 2,887 | 2,925 | 2,474 | 2,599 |
| Long-term debt | — | 47,858 | 39,370 | 40,868 | 40,943 | 34,255 | 34,585 | 28,527 | 29,117 | 23,848 | 24,679 | 18,425 |
| Total debt | — | 49,624 | 41,595 | 43,865 | 42,578 | 35,889 | 36,115 | 30,453 | 29,935 | 24,643 | 25,362 | — |
| Total liabilities | — | 108,404 | 85,378 | 85,941 | 91,085 | 82,574 | 73,542 | 64,443 | 61,286 | 58,239 | 51,046 | 53,143 |
| Total equity (incl. minority) | 33,879 | 33,879 | 31,198 | 26,535 | 23,851 | 18,349 | 15,847 | 14,272 | 14,321 | 13,636 | 12,897 | 10,864 |
| Retained earnings | — | 31,893 | 29,514 | 24,470 | 22,252 | 17,376 | 15,100 | 13,545 | 13,627 | 13,178 | 12,554 | 10,312 |
| Minority interest | — | — | — | — | 57.5 | 76.2 | 82.0 | — | 80.7 | 73.5 | 85.2 | 91.8 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 16,813 | 8,818 | 4,240 | 7,586 | 7,366 | 6,500 | 4,837 | 5,525 | 5,616 | 4,851 |
| Depreciation and amortization | 1,997 | 1,767 | 1,527 | 1,523 | 1,548 | 1,324 | 1,233 | 1,609 | 1,567 | 1,497 |
| Capital expenditure | -7,841 | -5,058 | -3,448 | -1,854 | -1,310 | -1,388 | -1,034 | -1,211 | -1,077 | -1,037 |
| Investing cash flow | -10,972 | -9,302 | -7,153 | -3,763 | -2,868 | -2,259 | -8,083 | 1,906 | -3,784 | -3,139 |
| Financing cash flow | -2,213 | 1,230 | 3,496 | -5,407 | -4,131 | -3,137 | -2,325 | -5,905 | 143 | -560 |
| Dividends paid | -5,384 | -4,680 | -4,069 | -3,536 | -3,087 | -2,687 | -2,410 | -2,312 | -2,192 | -2,159 |
| Share repurchases | -4,108 | -2,500 | -750 | -1,500 | -1,250 | -500 | -4,400 | -4,151 | -300 | -600 |
| Debt issued | 13,167 | 11,417 | 8,650 | 1,498 | 2,411 | 2,062 | 7,552 | 2,478 | 3,630 | 2,500 |
| Debt repaid | -5,116 | -2,516 | 0.0 | -1,560 | -1,909 | -1,771 | -2,866 | -3,207 | -631 | -0.2 |
| Effect of exchange rates | 372 | -297 | 169 | -168 | -206 | 216 | -89.9 | -63.6 | -20.5 | -236 |
| Net change in cash | 4,000 | 449 | 752 | -1,752 | 161 | 1,320 | -5,661 | 1,462 | 1,954 | 916 |
| Free cash flow | 8,972 | 3,760 | 792 | 5,731 | 6,056 | — | — | — | — | — |
| Levered free cash flow | 1,951 | 1,355 | 292 | 5,276 | 5,461 | 3,501 | 4,991 | 539 | 2,119 | 2,851 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 10,690 | 5,333 | 3,225 | 8,836 | 3,087 | 1,666 | 2,474 | 3,712 | 1,466 | 1,166 | -312 | 2,190 |
| Depreciation and amortization | 534 | 509 | 586 | 470 | 478 | 463 | 485 | 467 | 414 | 401 | 388 | 411 |
| Capital expenditure | -2,933 | -2,326 | -2,547 | -2,088 | -1,697 | -1,510 | -1,496 | -1,351 | -1,225 | -986 | -1,071 | -970 |
| Investing cash flow | -15,396 | -3,916 | -2,802 | -2,983 | -1,834 | -3,353 | -1,921 | -4,005 | -2,199 | -1,178 | -2,924 | -3,081 |
| Financing cash flow | 8,426 | -3,470 | -2,879 | 531 | -1,245 | 1,380 | -226 | 211 | 1,556 | -311 | 3,545 | 572 |
| Dividends paid | -1,546 | -1,548 | -1,346 | -1,345 | -1,347 | -1,346 | -1,168 | -1,171 | -1,172 | -1,169 | -1,018 | -1,016 |
| Share repurchases | -1,601 | -2,356 | -1,508 | -708 | -692 | -1,200 | -2,054 | -446 | — | — | — | — |
| Debt issued | 12,450 | 1,775 | -0.2 | 6,706 | 0.0 | 6,461 | -0.1 | 4,965 | 0.0 | 6,453 | 4,594 | 97.0 |
| Debt repaid | -873 | -750 | -0.3 | -4,092 | 825 | -1,849 | 3,042 | -3,089 | 2,736 | -5,205 | — | 1,498 |
| Effect of exchange rates | -52.0 | 67.0 | -67.1 | 31.7 | 275 | 132 | -429 | 227 | -59.6 | -35.5 | 129 | 5.3 |
| Net change in cash | 3,668 | -1,986 | -2,524 | 6,416 | 283 | -175 | -101 | 145 | 763 | -358 | 438 | -314 |
| Free cash flow | 7,757 | 3,007 | 678 | 6,748 | 1,390 | 156 | 978 | 2,361 | 241 | 180 | -1,383 | 1,219 |
| Levered free cash flow | 3,777 | 2,115 | 1,948 | 2,225 | 1,884 | -5,091 | 1,681 | -1,421 | 2,368 | -2,047 | -1,082 | -341 |
Financial statements of similar companies
Companies in the group: same industry, similar size
